findmyKOL
Clinical trialNCT02348203CompletedPhase 2Interventional

Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

SponsorNational Cancer Institute (NCI)Enrollment63Tobacco Use Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Linda L Garland

    The University of Arizona Medical Center-University Campus

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Banner University Medical Center - Tucson

    Tucson, Arizona, United States

  • Boston University School of Medicine

    Boston, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Jan 2016
Primary completion
22 Feb 2019
Completion
9 Mar 2021
Last update posted
2 Jun 2022
Registered enrollment
63
Registry id
NCT02348203

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.